跳至主要内容
临床试验/TCTR20170222001
TCTR20170222001终止未知

Intrapulmonary Penetration of Sitafloxacin and Treatment Outcomes in Thai Critically Ill Patients with Pneumonia

Ramathibodi Hospital0 个研究点目标入组 40 人开始时间: 2017年2月22日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1. aged more than 18 years who compatible with HAP/VAP
  • 2. respiratory failure which required mechanical ventilator to maintain oxygen saturation more than 90%
  • 3. hemodynamic stable, BP > 90/60
  • 4. new or progress of infiltration in chest radiology
  • 5. suspected pneumonia caused by A. baumannii, P. aeruginosa, and Extended Spectrum β-Lactamase (ESBL)-Gram negative pathogens, and/or received at least one antibiotics for empirical treatment of hospital-acquired infections.

排除标准

  • 1. patients or their authorities refuse to participate in this study
  • 2. patients who pregnant
  • 3. patients who lived with HIVS
  • 4. patients who have history with fluoroquinolone allergy
  • 5. patients who has contraindication to receive sitafloxacin
  • 6. patients who has contraindication to BAL
  • 7. patients who have QT prolongation (> 480 ms)
  • 8. patients who have history of recent unstable angina or myocardial infraction, increase ICP
  • 9. patients who have bleeding tendency eg. platelet less than 80,000, INR more than 1.3

研究者

相似试验